Peter I Jatlow, MD
Professor Emeritus of Laboratory Medicine and Senior Research Scientist in Psychiatry
Departments & Organizations
Yale Medical Group
Albert J. Solnit Integrated Training Program
NIMH Research Training Program in Childhood-onset Neuropsychiatric Disorders
Psychiatry: CENTURY: Core Directors
Laboratory Medicine: Clinical Chemistry
Research Interests
Clinical pharmacology of psychotropic drugs; cocaine; drugs of abuse; ethanol; nicotine dependence; more...
Education
- M.D., SUNY Downstate Medical Center, 1961
Selected Publications
- Jatlow P, Toll B, Leary V, Krishnan-Sarin S,S. O’Malley SS. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug and Alcohol Dependence 2008:98: 203-209.
- George TP, Vessicchio JC, Sacco KA Weinberger AH, Dudas MM,Allen TM,. Creeden CL, Potenza MN, andJatlow PI. A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation inSchizophrenia. Biol Psychiatry; 2008 63:1092–10968.
- Baker J, Jatlow P, Pade P, Ramakrishnan V, McCance-Katz EF. Acute Cocaine Responses Following Cocaethylene Infusion. 2007: J Drug and Alc Abuse, 33:619-625.
